Therapix Biosciences Ltd - ADR (TRPX) is near the bottom in its industry group according to InvestorsObserver. TRPX gets an overall rating of 4. That means it scores higher than 4 percent of stocks. Therapix Biosciences Ltd - ADR gets a 1 rank in the Biotechnology industry. Biotechnology is number 55 out of 148 industries.
Click Here to get the full Stock Score Report on Therapix Biosciences Ltd - ADR (TRPX) Stock.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 4 means the stock is more attractive than 4 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Therapix Biosciences Ltd - ADR Stock Today?
Therapix Biosciences Ltd - ADR (TRPX) stock is lower by -6.25% while the S&P 500 is up 0.09% as of 1:52 PM on Friday, Jan 10. TRPX has fallen -$0.06 from the previous closing price of $0.88 on volume of 71,454 shares. Over the past year the S&P 500 is up 26.22% while TRPX has fallen -77.93%. TRPX lost -$2.40 per share the over the last 12 months.
To see InvestorsObserver's Sentiment Score for Therapix Biosciences Ltd - ADR click here.
